HPV-associated head and neck cancer: Molecular and nano-scale markers for prognosis and therapeutic stratification

Sensors

Volumn 12, Issue 4, 2012, Pages 5159-5169

  Kimple, Adam J ^a   Torres, Alexandra D ^b,c   Yang, Robert Z ^b,c   Kimple, Randall J ^b,d  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d UNIVERSITY OF WISCONSIN   (United States)

Author keywords

Biomarkers; Head and neck cancer; Human papillomavirus; In situ hybridization; Next generation sequencing

Indexed keywords

HEAD AND NECK TUMOR; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; ISOLATION AND PURIFICATION; PAPILLOMA VIRUS; POLYMERASE CHAIN REACTION; PROGNOSIS; REVIEW; SOUTHERN BLOTTING; VIROLOGY; VIRUS INFECTION;

BLOTTING, SOUTHERN; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; PROGNOSIS; TUMOR VIRUS INFECTIONS;

EID: 84860173870     PISSN: 14248220     EISSN: None     Source Type: Journal    
DOI: 10.3390/s120405159     Document Type: Review

References (45)

1. Jemal, A.; Siegel, R.; Ward, E.; Hao, Y.; Xu, J.; Murray, T.; Thun, M.J. Cancer statistics, 2008. CA Cancer J. Clin. 2008, 58, 71-96.
2. Brizel, D.M. Head and neck cancer. Introduction. Semin. Radiat. Oncol. 2009, 19, 1-2.
3. Syrjanen, K.; Syrjanen, S.; Lamberg, M.; Pyrhonen, S.; Nuutinen, J. Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis. Int. J. Oral Surg. 1983, 12, 418-424.
4. Chaturvedi, A.K.; Engels, E.A.; Anderson, W.F.; Gillison, M.L. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the united states. J. Clin. Oncol. 2008, 26, 612-619.
5. Ang, K.K.; Harris, J.; Wheeler, R.; Weber, R.; Rosenthal, D.I.; Nguyen-Tan, P.F.; Westra, W.H.; Chung, C.H.; Jordan, R.C.; Lu, C.; et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N. Engl. J. Med. 2010, 363, 24-35.
6. Singhi, A.D.; Westra, W.H. Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience. Cancer 2010, 116, 2166-2173.
7. Sturgis, E.M.; Cinciripini, P.M. Trends in head and neck cancer incidence in relation to smoking prevalence: An emerging epidemic of human papillomavirus-associated cancers? Cancer 2007, 110, 1429-1435.
8. Munoz, N.; Bosch, F.X.; de Sanjose, S.; Herrero, R.; Castellsague, X.; Shah, K.V.; Snijders, P.J.; Meijer, C.J. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 2003, 348, 518-527.
9. Bae, J.H.; Lee, S.J.; Kim, C.J.; Hur, S.Y.; Park, Y.G.; Lee, W.C.; Kim, Y.T.; Ng, T.L.; Bock, H.L.; Park, J.S. Human papillomavirus (HPV) type distribution in korean women: A meta-analysis. J. Microbiol. Biotechnol. 2008, 18, 788-794.
10. Rischin, D.; Young, R.J.; Fisher, R.; Fox, S.B.; Le, Q.T.; Peters, L.J.; Solomon, B.; Choi, J.; O'Sullivan, B.; Kenny, L.M.; et al. Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on trog 02.02 phase III trial. J. Clin. Oncol. 2010, 28, 4142-4148.
11. Lewis, J.S., Jr.; Thorstad, W.L.; Chernock, R.D.; Haughey, B.H.; Yip, J.H.; Zhang, Q.; El-Mofty, S.K. P16 positive oropharyngeal squamous cell carcinoma: An entity with a favorable prognosis regardless of tumor hpv status. Am. J. Surg. Pathol. 2010, 34, 1088-1096.
12. Herrero, R.; Castellsague, X.; Pawlita, M.; Lissowska, J.; Kee, F.; Balaram, P.; Rajkumar, T.; Sridhar, H.; Rose, B.; Pintos, J.; et al. Human papillomavirus and oral cancer: The international agency for research on cancer multicenter study. J. Natl. Cancer Inst. 2003, 95, 1772-1783.
13. Hong, A.M.; Grulich, A.E.; Jones, D.; Lee, C.S.; Garland, S.M.; Dobbins, T.A.; Clark, J.R.; Harnett, G.B.; Milross, C.G.; O'Brien, C.J.; et al. Squamous cell carcinoma of the oropharynx in australian males induced by human papillomavirus vaccine targets. Vaccine 2010, 28, 3269-3272.
14. Conway, D.I.; Stockton, D.L.; Warnakulasuriya, K.A.; Ogden, G.; Macpherson, L.M. Incidence of oral and oropharyngeal cancer in united kingdom (1990-1999)-Recent trends and regional variation. Oral Oncol. 2006, 42, 586-592.
15. Chaturvedi, A.K.; Engels, E.A.; Pfeiffer, R.M.; Hernandez, B.Y.; Xiao, W.; Kim, E.; Jiang, B.; Goodman, M.T.; Sibug-Saber, M.; Cozen, W.; et al. Human papillomavirus and rising oropharyngeal cancer incidence in the united states. J. Clin. Oncol. 2011, 29, 4294-4301.
16. Fakhry, C.; Westra, W.H.; Li, S.; Cmelak, A.; Ridge, J.A.; Pinto, H.; Forastiere, A.; Gillison, M.L. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J. Natl. Cancer Inst. 2008, 261-269.
17. Shah, N.G.; Trivedi, T.I.; Tankshali, R.A.; Goswami, J.V.; Jetly, D.H.; Shukla, S.N.; Shah, P.M.; Verma, R.J. Prognostic significance of molecular markers in oral squamous cell carcinoma: A multivariate analysis. Head Neck 2009, 31, 1544-1556.
18. Weinberger, P.M.; Yu, Z.; Haffty, B.G.; Kowalski, D.; Harigopal, M.; Sasaki, C.; Rimm, D.L.; Psyrri, A. Prognostic significance of p16 protein levels in oropharyngeal squamous cell cancer. Clin. Cancer Res. 2004, 10, 5684-5691.
19. Reimers, N.; Kasper, H.U.; Klussmann, J.P. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. Int. J. Cancer 2007, 120, 1731-1738.
20. Fischer, C.A.; Kampmann, M.; Zlobec, I.; Green, E.; Tornillo, L.; Lugli, A.; Wolfensberger, M.; Terracciano, L.M. P16 expression in oropharyngeal cancer: Its impact on staging and prognosis compared with the conventional clinical staging parameters. Ann. Oncol. 2010, 21, 1961-1966.
21. Mehanna, H.; Olaleye, O.; Licitra, L. Oropharyngeal cancer-Is it time to change management according to human papilloma virus status? Curr. Opin. Otolaryngol. Head Neck Surg. 2012, accept.
22. Lassen, P. The role of human papillomavirus in head and neck cancer and the impact on radiotherapy outcome. Radiother. Oncol. 2010, 95, 371-380.
23. Southern, E.M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 1975, 98, 503-517.
24. Southern, E. Southern blotting. Nat. Protoc. 2006, 1, 518-525.
25. Schiffman, M.H.; Bauer, H.M.; Lorincz, A.T.; Manos, M.M.; Byrne, J.C.; Glass, A.G.; Cadell, D.M.; Howley, P.M. Comparison of southern blot hybridization and polymerase chain reaction methods for the detection of human papillomavirus DNA. J. Clin. Microbiol. 1991, 29, 573-577.
26. Kraft, S.; Faquin, W.C.; Krane, J.F. HPV-associated neuroendocrine carcinoma of the oropharynx: A rare new entity with potentially aggressive clinical behavior. Am. J. Surg. Pathol. 2012, 36, 321-330.
27. Caussy, D.; Orr, W.; Daya, A.D.; Roth, P.; Reeves, W.; Rawls, W. Evaluation of methods for detecting human papillomavirus deoxyribonucleotide sequences in clinical specimens. J. Clin. Microbiol. 1988, 26, 236-243.
28. Kim, C.J.; Jeong, J.K.; Park, M.; Park, T.S.; Park, T.C.; Namkoong, S.E.; Park, J.S. HPV oligonucleotide microarray-based detection of hpv genotypes in cervical neoplastic lesions. Gynecol. Oncol. 2003, 89, 210-217.
29. Seo, S.S.; Song, Y.S.; Kim, J.W.; Park, N.H.; Kang, S.B.; Lee, H.P. Good correlation of HPV DNA test between self-collected vaginal and clinician-collected cervical samples by the oligonucleotide microarray. Gynecol. Oncol. 2006, 102, 67-73.
30. Szarewski, A.; Ambroisine, L.; Cadman, L.; Austin, J.; Ho, L.; Terry, G.; Liddle, S.; Dina, R.; McCarthy, J.; Buckley, H.; et al. Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smears. Cancer Epidemiol. Biomark. Prev. 2008, 17, 3033-3042.
31. Heid, C.A.; Stevens, J.; Livak, K.J.; Williams, P.M. Real time quantitative PCR. Genome Res 1996, 6, 986-994.
32. Liu, B.; Lu, Z.; Wang, P.; Basang, Z.; Rao, X. Prevalence of high-risk human papillomavirus types (HPV-16, HPV-18) and their physical status in primary laryngeal squamous cell carcinoma. Neoplasma 2010, 57, 594-600.
33. Huang, L.W.; Chao, S.L.; Lee, B.H. Integration of human papillomavirus type-16 and type-18 is a very early event in cervical carcinogenesis. J. Clin. Pathol. 2008, 61, 627-631.
34. Metzker, M.L. Sequencing technologies-The next generation. Nat. Rev. Genet. 2010, 11, 31-46.
35. Kohlmann, A.; Grossmann, V.; Haferlach, T. Integration of next-generation sequencing into clinical practice: Are we there yet? Semin. Oncol. 2012, 39, 26-36.
36. Barzon, L.; Militello, V.; Lavezzo, E.; Franchin, E.; Peta, E.; Squarzon, L.; Trevisan, M.; Pagni, S.; Dal Bello, F.; Toppo, S.; et al. Human papillomavirus genotyping by 454 next generation sequencing technology. J. Clin. Virol. 2011, 52, 93-97.
37. Conway, C.; Chalkley, R.; High, A.; Maclennan, K.; Berri, S.; Chengot, P.; Alsop, M.; Egan, P.; Morgan, J.; Taylor, G.R.; et al. Next-generation sequencing for simultaneous determination of human papillomavirus load, subtype, and associated genomic copy number changes in tumors. J. Mol. Diagn. 2012, 14, 104-111.
38. Kreimer, A.R.; Clifford, G.M.; Snijders, P.J.; Castellsague, X.; Meijer, C.J.; Pawlita, M.; Viscidi, R.; Herrero, R.; Franceschi, S. HPV16 semiquantitative viral load and serologic biomarkers in oral and oropharyngeal squamous cell carcinomas. Int. J. Cancer 2005, 115, 329-332.
39. Anderson, K.S.; Wong, J.; D'Souza, G.; Riemer, A.B.; Lorch, J.; Haddad, R.; Pai, S.I.; Longtine, J.; McClean, M.; LaBaer, J.; et al. Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancer. Br. J. Cancer 2011, 104, 1896-1905.
40. Harris, S.L.; Thorne, L.B.; Seaman, W.T.; Hayes, D.N.; Couch, M.E.; Kimple, R.J. Association of p16(INK4A) overexpression with improved outcomes in young patients with squamous cell cancers of the oral tongue. Head Neck 2011, 33, 1622-1627.
41. Chau, N.G.; Perez-Ordonez, B.; Zhang, K.; Pham, N.A.; Ho, J.; Zhang, T.; Ludkovski, O.; Wang, L.; Chen, E.X.; Tsao, M.S.; et al. The association between egfr variant III, HPV, p16, c-MET, EGFR gene copy number and response to EGFR inhibitors in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. Head Neck Oncol. 2011, doi: 10.1186/1758-3284-3-11.
42. Gillison, M.L.; Harris, J.; Westra, W.; Chung, C.; Jordan, R.; Rosenthal, D.; Nguyen-Tan, P.; Spanos, W.J.; Redmond, K.P.; Ang, K.; et al. Survival outcomes by tumor human papillomavirus (HPV) status in stage III-IV oropharyngeal cancer (OPC) in RTOG 0129. J. Clin. Oncol. (Meeting Abstracts) 2009, 27, 6003.
43. Thomas, J.; Primeaux, T. Is p16 immunohistochemistry a more cost-effective method for identification of human papilloma virus-associated head and neck squamous cell carcinoma? Ann. Diagn. Pathol. 2011, 16, 91-99.
44. Schache, A.G.; Liloglou, T.; Risk, J.M.; Filia, A.; Jones, T.M.; Sheard, J.; Woolgar, J.A.; Helliwell, T.R.; Triantafyllou, A.; Robinson, M.; et al. Evaluation of human papilloma virus diagnostic testing in oropharyngeal squamous cell carcinoma: Sensitivity, specificity, and prognostic discrimination. Clin. Cancer Res. 2011, 17, 6262-6271.
45. Shi, W.; Kato, H.; Perez-Ordonez, B.; Pintilie, M.; Huang, S.; Hui, A.; O'Sullivan, B.; Waldron, J.; Cummings, B.; Kim, J.; et al. Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma. J. Clin. Oncol. 2009, 27, 6213-6221.